Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
GPCR rhodopsin (GPCR-1) | ||||||
Orexin receptor type 1 (HCRTR1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (SB334867) of HCRTR1 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that inhibition of HCRTR1 leads to the decrease of ATP levels compared with control group. | |||||
Hydrolases (EC 3) | ||||||
Extracellular sulfatase Sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of Sulf1 | |||||
Induced Change | ATP concentration: increase (FC = 1.37) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
Details | It is reported that knockout of Sulf1 leads to the increase of ATP levels compared with control group. | |||||
Phosphoinositide lipid phosphatase (PLIP) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Knockout of Ptpmt1 | |||||
Induced Change | ATP concentration: decrease (FC= 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Ptpmt1 leads to the decrease of ATP levels compared with control group. | |||||
Sulfatase sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockdown (shRNA) of SULF1 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
Details | It is reported that knockdown of SULF1 leads to the increase of ATP levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of SULF1 | |||||
Induced Change | ATP concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
Details | It is reported that overexpression of SULF1 leads to the decrease of ATP levels compared with control group. | |||||
Ligases (EC 6) | ||||||
Methylcrotonoyl-CoA carboxylase alpha (MCCC1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Mutation ( c.1263dupG, p.Q421AfsX10; c.1263dupG/c.1682-3A>G, p.Q421AfsX10/p.N561KfsX10) of MCCC1 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lipid metabolism disorders [ICD-11: 5C52] | |||||
Details | It is reported that mutation ( c.1263dupG, p.Q421AfsX10; c.1263dupG/c.1682-3A>G, p.Q421AfsX10/p.N561KfsX10) of MCCC1 leads to the decrease of ATP levels compared with control group. | |||||
Mitochondrial carrier (MC) | ||||||
Oxoglutarate/malate carrier protein (SLC25A11) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Knockdown (siRNA) of SLC25A11 | |||||
Induced Change | ATP concentration: decrease (FC = 0.25) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that knockdown of SLC25A11 leads to the decrease of ATP levels compared with control group. | |||||
Oxidoreductases (EC 1) | ||||||
Formyltetrahydrofolate dehydrogenase (ALDH1L2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Mutation of ALDH1L2 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Genetic disorders of keratinisation [ICD-11: EC20] | |||||
Details | It is reported that mutation (patients) of ALDH1L2 leads to the decrease of ATP levels compared with control group. | |||||
Glucose-6-phosphate dehydrogenase (G6PD) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockdown (siRNA) of G6PD | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of G6PD leads to the decrease of ATP levels compared with control group. | |||||
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockdown (siRNA) of Gapdh | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of Gapdh leads to the decrease of ATP levels compared with control group. | |||||
Sodium/anion cotransporter (SAC) | ||||||
Solute carrier family 17 member 9 (SLC17A9) | Click to Show/Hide the Full List of Regulating Pair(s): 4 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Knockdown (siRNA) of Slc17a9 | |||||
Induced Change | ATP concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Adrenomedullary hyperfunction [ICD-11: 5A75] | |||||
Details | It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Knockdown (siRNA) of SLC17A9 | |||||
Induced Change | ATP concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Adrenomedullary hyperfunction [ICD-11: 5A75] | |||||
Details | It is reported that knockdown of SLC17A9 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Knockdown (shRNA) of Slc17a9 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Overexpression of Slc17a9 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Slc17a9 leads to the increase of ATP levels compared with control group. | |||||
Sugar transporter (ST) | ||||||
Facilitated glucose transporter 1 (SLC2A1A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Downregulation of slc2a1a caused by Yap loss-of-function mutation | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that downregulation of slc2a1a caused by Yap loss-of-function mutation leads to the decrease of ATP levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Hypoxia-inducible factor 1-alpha (HIF1A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (YC-1) of HIF1A | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that inhibition of HIF1A leads to the decrease of ATP levels compared with control group. | |||||
Transcriptional coactivator (TC) | ||||||
Transcriptional coactivator YAP1 (yap1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Decrease of Yap mRNA caused by Yap loss-of-function mutation | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of ATP levels compared with control group. | |||||
Transferases (EC 2) | ||||||
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) | Click to Show/Hide the Full List of Regulating Pair(s): 3 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Knockdown (shRNA) of PFKFB4 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] ... | |||||
Details | It is reported that knockdown of PFKFB4 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Overexpression of PFKFB4 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] ... | |||||
Details | It is reported that overexpression of PFKFB4 leads to the increase of ATP levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Knockdown (shRNA) of Pfkfb4 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lung cancer [ICD-11: 2C25] | |||||
Details | It is reported that knockdown of Pfkfb4 leads to the decrease of ATP levels compared with control group. | |||||
Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[12] | ||||
Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Prostate cancer [ICD-11: 2C82] | |||||
Details | It is reported that inhibition of ICMT leads to the decrease of ATP levels compared with control group. | |||||
Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[13] | ||||
Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of Pdxk | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
Details | It is reported that knockout of Pdxk leads to the decrease of ATP levels compared with control group. | |||||
Transaldolase (TALDO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[14] | ||||
Introduced Variation | Knockout of Taldo1 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Taldo1 leads to the increase of ATP levels compared with control group. | |||||
Transketolase-like protein 1 (TKTL1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[15] | ||||
Introduced Variation | Overexpression of TKTL1 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Head and neck squamous cell carcinoma [ICD-11: 2D60] | |||||
Details | It is reported that overexpression of TKTL1 leads to the increase of ATP levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.